Skip to main content

Table 3 Outcomes comparing Observation vs CLND in SLNB positive patients

From: Lymphadenectomy after a positive sentinel node biopsy in patients with cutaneous melanoma. A systematic review

AUTOR

OS 3y

p

OS 5y

p

MSS-3y

p

MSS-5y

p

DFS-3y

p

DFS-5y

p

Obs.

CLND

 

Obs.

CLND

 

Obs.

CLND

 

Obs.

CLND

 

Obs.

CLND

 

Obs.

CLND

 

Bamboat (Bamboat et al., 2014)

      

79%a

73%a

0.09

69%a

62%a

0.09

37%a

50%a

 

29%a

41%a

 

Satzger (Satzger et al., 2014)

         

81%a

71%a

    

71%a

56%a

 

Ploeg (van der Ploeg et al., 2014)

                  

Melstrom (Melstrom et al., 2014)

   

35%a

37%a

0.6

            

Gyorki (Gyorki et al., 2014)

               

33%

40%

0.34

Fritsch (Fritsch et al., 2016)

                  

Mosquera (Mosquera et al., 2017)

         

70%

72%

0.83

      

Lee (Lee et al., 2016)

         

66%

74%

0.015

   

55%

49%

0.21

Faries (Faries et al., 2017)

      

86%

86%

0.42

   

63%

68%

0.05

   

Klemen (Klemen et al., 2019)

   

59%

64%

0.084

   

66%

71%

0.161

      

Leiter (Leiter et al., 2019)

82%

81%

0.87

71%

72%

0.94

      

67%

67%

0.75

61%

60%

0.94

  1. Obs Observation, CLND Completion lymph node lymphadenectomy, Obs. Observation, OS Overall Survival, MSS Melanoma specific survival, DFS Disease free survival. aData extracted by software (PlotDigitizer®)